Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

MediWound (MDWD) Share-based Compensation (IS) (2016 - 2025)

MediWound has reported Share-based Compensation (IS) over the past 13 years, most recently at $740000.0 for Q3 2025.

  • For Q3 2025, Share-based Compensation (IS) fell 29.25% year-over-year to $740000.0; the TTM value through Sep 2025 reached $3.3 million, up 25.02%, while the annual FY2024 figure was $3.1 million, 61.75% up from the prior year.
  • Share-based Compensation (IS) for Q3 2025 was $740000.0 at MediWound, down from $862000.0 in the prior quarter.
  • Over five years, Share-based Compensation (IS) peaked at $1.0 million in Q3 2024 and troughed at -$311000.0 in Q3 2023.
  • A 5-year average of $553736.8 and a median of $619000.0 in 2023 define the central range for Share-based Compensation (IS).
  • Biggest five-year swings in Share-based Compensation (IS): tumbled 143.99% in 2023 and later surged 436.33% in 2024.
  • Year by year, Share-based Compensation (IS) stood at $390000.0 in 2021, then surged by 64.62% to $642000.0 in 2022, then plummeted by 53.58% to $298000.0 in 2023, then surged by 175.84% to $822000.0 in 2024, then dropped by 9.98% to $740000.0 in 2025.
  • Business Quant data shows Share-based Compensation (IS) for MDWD at $740000.0 in Q3 2025, $862000.0 in Q2 2025, and $844000.0 in Q1 2025.